Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.89 USD | -0.34% | -6.48% | +74.72% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.72% | 1.32B | |
+38.35% | 727B | |
-7.01% | 354B | |
+17.79% | 328B | |
+0.63% | 277B | |
+14.28% | 243B | |
+7.47% | 205B | |
-5.93% | 203B | |
+5.08% | 164B | |
-0.78% | 164B |
- Stock Market
- Equities
- TARS Stock
- News Tarsus Pharmaceuticals, Inc.
- Tarsus Pharmaceuticals Says Phase 2a Trial of TP-03 in Meibomian Gland Disease Yields Positive Results